Who Paid My Doc
Janet Englund
Pediatric Infectious Diseases Seattle, WA Medical Doctor
NPI 1679663561 CMS profile 211892
4800 Sand Point Way Ne, Seattle, WA 98105
General payments
$247,598
Research payments
$8,460
Ownership & investment interest
$0
Research they led as principal investigator
$5,828,916
Through program year 2025, Janet Englund of Seattle, WA is reported in the CMS Open Payments database as having received $247,598 across 131 general payments and $8,460 in research payments paid to them. Separately, studies naming them as principal investigator received $5,828,916 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Pediatric Infectious Diseases profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $90,474 | 24 | |
| 2024 | General | $78,787 | 26 | |
| 2023 | General | $6,047 | 8 | |
| 2023 | Research | $5,260 | 4 | |
| 2022 | General | $24,574 | 18 | |
| 2022 | Research | $3,200 | 1 | |
| 2021 | General | $16,752 | 8 | |
| 2020 | General | $13,685 | 7 | |
| 2019 | General | $17,280 | 40 |
Beside peers
- Janet Englund
- Pediatric Infectious Diseases median
- Middle half of Pediatric Infectious Diseases
- National median
In program year 2025, general payments to Janet Englund were reported at $90,474. Among 311 Pediatric Infectious Diseases profiles paid that year, the median was $126 and the middle half received between $41 and $2,094.
Show as a table
| Year | Janet Englund | Pediatric Infectious Diseases median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $17,280 | $175 | $34–$2,175 | $163 |
| 2020 | $13,685 | $521 | $34–$6,009 | $114 |
| 2021 | $16,752 | $1,077 | $39–$4,557 | $132 |
| 2022 | $24,574 | $232 | $53–$6,196 | $149 |
| 2023 | $6,047 | $140 | $52–$4,662 | $160 |
| 2024 | $78,787 | $198 | $52–$3,860 | $164 |
| 2025 | $90,474 | $126 | $41–$2,094 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
136 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Infectious Diseases in Washington
Alpana Waghmare
Pediatric Infectious Diseases · Seattle, WA
Tamara Pozos
Pediatric Infectious Diseases · Seattle, WA
Surabhi Vora
Pediatric Infectious Diseases · Seattle, WA
Horacio Duarte
Pediatric Infectious Diseases · Seattle, WA
Mary Fairchok
Pediatric Infectious Diseases · Tacoma, WA
Anjali Kunz
Pediatric Infectious Diseases · Tacoma, WA
Related records
Pediatric Infectious Diseases in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Infectious Diseases
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.